NCT03601754

Brief Summary

This study is a prospective, non-randomized pilot study looking to evaluate the effectiveness of Closed Loop Stimulation (CLS) in sinus node dysfunction patients with HIS bundle placement. Patients with sinus node dysfunction who have previously received a Biotronik pacemaker with His bundle lead placement as part of routine care will be recruited for the study. A hand-grip exercise will be performed at the conclusion of bicycle exercise testing in order to assess the performance of CLS during isometric exercise. After the study exercise testing is completed, data will be collected from the pacemaker.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

July 19, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 26, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2019

Completed
Last Updated

November 18, 2019

Status Verified

November 1, 2019

Enrollment Period

7 months

First QC Date

May 2, 2018

Last Update Submit

November 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in heart rate from baseline to Day 30

    Ability to achieve adequate heart rate, defined as reaching upper sensor rate, during peak exertion

    Day 1, Day 30

Secondary Outcomes (1)

  • Greater heart response with CLS compared to predicted accelerometer based heart rate response

    Day 1, Day 30

Study Arms (1)

Closed Loop Stimulation (CLS)

EXPERIMENTAL

Prior to enrollment, the patient would have received Biotronik pacemaker with His bundle lead placement for at least 30 days and CLS will be programmed ON for at least 7 days as part of routine care.

Diagnostic Test: Treadmill/Bicycle exercise testing

Interventions

Exercise testing will be scheduled on the same day as the enrollment visit and within 30 days after post-implant visit. The standard protocol will be typically set at an initial workload of 15Watts and go up by increments of 10 Watts every 3 minutes, as follows: Stage 1 - 15 W Stage 2 - 25 W Stage 3 - 35 W Stage 4 - 45 W

Closed Loop Stimulation (CLS)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Documented sinus node dysfunction
  • Biotronik pacemaker implanted with His bundle lead placement for standard indications
  • Implanted at least 30 days
  • CLS has been enabled for at least 7 days or will be programmed ON for at least 7 days prior to exercise test
  • Leads and device are functioning appropriately

You may not qualify if:

  • Inability to complete treadmill/bicycle exercise test
  • Planned surgical revision or replacement of the device and/or leads
  • Patients who are unwilling or unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Sick Sinus Syndrome

Condition Hierarchy (Ancestors)

Arrhythmia, SinusArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesHeart BlockCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Chirag Barbhaiya, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2018

First Posted

July 26, 2018

Study Start

July 19, 2018

Primary Completion

January 31, 2019

Study Completion

January 31, 2019

Last Updated

November 18, 2019

Record last verified: 2019-11

Locations